Literature DB >> 12425257

Benefits of a mobile, point-of-care anticoagulation therapy management program.

James M Gill1, Mark K Landis.   

Abstract

BACKGROUND: Current guidelines recommend anticoagulation therapy for a number of medical conditions, but this therapy also has the potential for serious complications, particularly bleeding complications. Maintenance of anticoagulation within a narrow therapeutic window usually entails frequent monitoring with a blood test called the international normalized ratio (INR). Anticoagulation therapy management (ATM) clinics lead to improvements in quality of care, in terms of improved INR control and reduced complications. This study examined the impact of a mobile multisite, office-based ATM program that operated in seven cardiology offices in all three counties in Delaware. ATM PROGRAM: The ATM program was managed by a trained nurse who rotated among all seven offices. Patients made office visits to the nurse and received patient education, point-of-care INR testing, and medication adjustment based on a physician-approved algorithm.
METHODS: This retrospective cohort study compared INR levels in the year before (May 1998-Apr 1999) and the year after (Aug 1999-Jul 2000) the start of the ATM program.
RESULTS: From the year before to the year after implementation of the ATM program, the percentage of in-range INRs increased from 40.7% to 58.5% (p < 0.001). The percentage in the modified target range also increased (50.0% to 62.9%, p < 0.001). DISCUSSION: This study demonstrates the positive impact of a statewide office-based ATM program. If similar programs could be implemented in other networks of specialty offices or primary care offices, they could have a significant benefit to quality of care for patients who require anticoagulation therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425257     DOI: 10.1016/s1070-3241(02)28066-9

Source DB:  PubMed          Journal:  Jt Comm J Qual Improv        ISSN: 1070-3241


  7 in total

1.  Barriers to the use of warfarin: potential solutions.

Authors:  John H McAnulty
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 2.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

3.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

4.  Improving anticoagulation therapy using point-of-care testing and a standardized protocol.

Authors:  Curtis A Franke; Lori M Dickerson; Peter J Carek
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

5.  POINT-OF-CARE HEMATOLOGY AND COAGULATION TESTING IN PRIMARY, RURAL EMERGENCY, AND DISASTER CARE SCENARIOS.

Authors:  Corbin M Curtis; Gerald J Kost; Richard F Louie; Rebecca J Sonu; Erika B Ammirati; Stephanie Sumner
Journal:  Point Care       Date:  2012-06

6.  A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting.

Authors:  Jennifer Rossiter; Gursharan Soor; Deanna Telner; Babak Aliarzadeh; Jennifer Lake
Journal:  Int J Family Med       Date:  2013-12-12

7.  Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic.

Authors:  Kaveh Rezaei Bookani; Iva Minga; Manisha Chander; Ksenia Hankewych; Matthew Plassmeier; Alfonso Tafur
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.